• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [16962 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Angiogenesis inhibitors (bevacizumab - ranibizumab) in neovascular glaucoma and corneal neovascularization]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Darunavir-cobicistat-emtricitabine-tenofovir alafenamide (HIV infection) - benefit assessment according to §35a Social Code Book V]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Bariatric surgery as treatment for obesity in subjects over 65 years old]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Avelumab (metastatic Merkel cell carcinoma) - benefit assessment according to §35a (1), sentence 11, Social Code Book V]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) Bariatric surgery to treat obesity in individuals under 21 years old
2017     HAYES, Inc. Dorsal root ganglion stimulation for the treatment of complex regional pain syndrome
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Usefulness of N-terminal type B natriuretic propeptide in amyloidosis]
2017     HAYES, Inc. Flexitouch system (Tactile Systems Technology Inc.) for lymphedema
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Dynamic magnetic resonance imaging in pelvic floor dysfunction]
2017     HAYES, Inc. Glucagon-like peptide-1 receptor agonists for the treatment of obesity in women with polycystic ovary syndrome
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Reducing mammaplasty for the treatment of patients with breast hypertrophy and chronic dorsalgia]
2017     HAYES, Inc. iFuse Implant System (SI-Bone Inc.) for sacroiliac joint fusion for treatment of sacroiliac joint dysfunction
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Arterial stiffness measurement for cardiovascular risk classification in high blood pressure patients]
2017     HAYES, Inc. Gore cardioform septal occluder (W.L. Gore & Associates) for closure of atrial septal defects
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Intrathecal opioid infusion pump for chronic cancer and non-cancer pain]
2017     HAYES, Inc. Impella 2.5 System (Abiomed Inc.) for cardiac support in patients undergoing high-risk percutaneous coronary intervention
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Nonmydriatic stereoscopic retinal imaging for retinal condition]
2017     HAYES, Inc. Intravenous immunoglobulin for treatment of intractable epilepsy in pediatric patients
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Transbronchial lung cryobiopsy in diffuse interstitial lung disease diagnosis]
2017     HAYES, Inc. Ketamine infusion for treatment-resistant bipolar depression
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Cryoablation for the treatment of persistent or symptomatic paroxysmal atrial fibrillation]
2017     HAYES, Inc. Micra transcatheter pacing system (Medtronic Inc.) for single-chamber pacemaker indications
2017     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of treat-to-target strategies in rheumatoid arthritis: a systematic review and cost-effectiveness analysis
2017     Institute for Clinical Effectiveness and Health Policy (IECS) Biofeedback for women with urinary, fecal or combined incontinence
2017     HAYES, Inc. Ocrelizumab (Ocrevus; Genentech Inc.) for primary progressive and relapsing-remitting multiple sclerosis
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Pomalidomide for relapsed and refractory myeloma]
2017     HAYES, Inc. Radiofrequency nerve ablation for treatment of plantar fasciitis
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Epidermal growth factor (Heberprot-P®) in chronic ulcers]
2017     HAYES, Inc. Raindrop near vision inlay (ReVision Optics Inc.) for presbyopia
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Biological agents and tofacitinib in rheumatoid arthritis]
2017     HAYES, Inc. Teduglutide (Gattex; Shire-NPS Pharmaceuticals Inc.) to reduce parenteral support requirements in adults with short bowel syndrome
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Stiripentol for the treatment of severe myoclonic epilepsy in infants (dravet's syndrome)]
2017     HAYES, Inc. Urolift system (NeoTract Inc.) for treatment of benign prostatic hyperplasia
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Cannabinoids in patients with autism spectrum disorders]
2017     HAYES, Inc. Afirma thyroid FNA analysis (Veracyte)
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Transanal endoscopic microsurgery (tem) and transanal minimally invasive surgery (tamis) for the treatment of rectal lesions]
2017     HAYES, Inc. AlloSure (CareDx)
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Intensity-modulated radiation therapy for breast cancer]
2017     HAYES, Inc. Cologuard (Exact Sciences Corp.)
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Invasive electroencephalography monitoring with depth electrodes in presurgical assessment of patients with refractory epilepsy]
2017     HAYES, Inc. GeneStrat (Biodesix Inc.)
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Gadoxetic acid-enhanced magnetic resonance imaging to diagnose focal liver lesions]
2017     HAYES, Inc. OVA1 (ASPiRA Labs)
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Intradialytic parenteral nutrition in patients with chronic kidney conditions]
2017     HAYES, Inc. ThyGenX and ThyraMIR (Interpace Diagnostics)
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Whole exome sequencing in patients with undiagnosed neurological diseases]
2017     HAYES, Inc. Comparative effectiveness of bioresorbable vascular scaffold stents versus other drug-eluting stents for the treatment of coronary artery disease
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Posterior tibial nerve stimulation in overactive bladder]
2017     HAYES, Inc. Comparative effectiveness of endovenous radiofrequency ablation versus conventional surgery for symptomatic varicose veins: a review of reviews
2017     NIHR Health Technology Assessment programme Managing diabetes in people with dementia: a realist review
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Diode laser vaporization in benign prostatic hyperplasia]
2017     HAYES, Inc. Comparative effectiveness of skin substitutes for chronic foot ulcers in adults with diabetes mellitus: a review of reviews
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Motorized Intramedullary nails for bone lenghtening in achondroplasia or hypochondropasia]
2017     HAYES, Inc. Comparative effectiveness of skin substitutes for chronic venous leg ulcers in adults: a review of reviews
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Dimethyl fumarate in multiple sclerosis: Comparison among different commercially available trademarks in Argentina]
2017     HAYES, Inc. Comparative effectiveness review of antimicrobial versus conventional sutures
2017     NIHR Health Technology Assessment programme Systematic review of interventions for treating or preventing antipsychotic-induced tardive dyskinesia
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Dynamic fixation for spine degenerative diseases]
2017     HAYES, Inc. Comparative effectiveness review of endoscopic therapy for gastroesophageal reflux disease
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Autologous lymph node transfer for lymphedema secondary to breast cancer]
2017     HAYES, Inc. Comparative effectiveness review of hyaluronic acid for knee osteoarthritis: a review of reviews
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Fractional exhaled nitric oxide measurement in patients with asthma and chronic cough]
2017     HAYES, Inc. Comparative effectiveness review of minimally invasive total hip arthroplasty
2017     Norwegian Institute for Public Health Assessment of conductive education for children and adolescents with brain damage: a health technology assessment
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Negative pressure therapy in chronic wounds]
2017     HAYES, Inc. Comparative effectiveness review of multilevel artificial disc replacement for cervical degenerative disc disease
2017     Norwegian Institute for Public Health Digital Breast Tomosynthesis with Hologic 3D mammography Selenia Dimensions System for use in breast cancer screening
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Nintedanib in lung cancer]
2017     HAYES, Inc. Comparative effectiveness review of nonirradiated allografts for primary anterior cruciate ligament reconstruction
2017     Norwegian Institute for Public Health Sutureless aortic valve replacement for treatment of severe aortic stenosis: A single technology assessment of Perceval sutureless aortic valve
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Genetic sequencing panel for motor-sensory hereditary neuropathy diagnosis]
2017     HAYES, Inc. Comparative effectiveness review of platelet-rich plasma for knee osteoarthritis: a review of reviews
2017     Norwegian Institute for Public Health FreeStyle Libre Flash Glucose Self-Monitoring System: A Single-Technology Assessment
2017     NIHR Health Technology Assessment programme Researching outcomes from forensic services for people with intellectual or developmental disabilities: a systematic review, evidence synthesis and expert and patient/carer consultation
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [3D Echocardiography in heart valve diseases]
2017     HAYES, Inc. Comparative effectiveness review of platelet-rich plasma for tendinopathies or ligament injuries of the knee
2017     Norwegian Institute for Public Health Assessment of four intensive habilitation programs for children and adolescents with brain damage – a health technology assessment
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Nusinersen (Spinraza®) in spinal muscular atrophy]
2017     HAYES, Inc. Comparative effectiveness review of platelet-rich plasma for treatment of lateral epicondylitis: a review of reviews
2017     Swiss Federal Office of Public Health (FOPH) Health technology assessment on spinal Implants
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Olaparib in ovarian cancer]
2017     HAYES, Inc. Comparative effectiveness review of pyrocarbon proximal interphalangeal and metacarpophalangeal joint implants
2017     NIHR Health Technology Assessment programme Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Nivolumab for the treatment of advanced melanoma]
2017     HAYES, Inc. Comparative effectiveness review of total ankle replacement: a review of reviews
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Ceritinib in lung cancer]
2017     HAYES, Inc. Digital breast tomosynthesis for breast cancer diagnosis and screening
2017     HAYES, Inc. Functional electrical stimulation for rehabilitation following spinal cord injury
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Nivolumab (classical Hodgkin lymphoma) - addendum to Commission A16-76]
2017     HAYES, Inc. Hyperbaric oxygen therapy for diabetes-related foot ulcers: a review of reviews
2017     NIHR Health Technology Assessment programme A multicentre randomiSed controlled TRial of IntraVEnous immunoglobulin compared with standard therapy for the treatment of transverse myelitis in adults and children (STRIVE)
2017     HAYES, Inc. Impact of preoperative supervised weight loss programs on bariatric surgery outcomes
2017     NIHR Health Technology Assessment programme Aquatic therapy for children with Duchenne muscular dystrophy: a pilot feasibility randomised controlled trial and mixed-methods process evaluation
2017     HAYES, Inc. Ketamine as an adjunct to electroconvulsive therapy for treatment-resistant depression
2017     NIHR Health Technology Assessment programme Development of a core outcome set for disease modification trials in mild to moderate dementia: a systematic review, patient and public consultation and consensus recommendations
2017     HAYES, Inc. Ketamine as primary therapy for treatment-resistant unipolar depression or posttraumatic stress disorder
2017     NIHR Health Technology Assessment programme Improving risk adjustment in the PRAiS (Partial Risk Adjustment in Surgery) model for mortality after paediatric cardiac surgery and improving public understanding of its use in monitoring outcomes
2017     NIHR Health Technology Assessment programme The clinical effectiveness of different surveillance strategies to prevent colorectal cancer in people with intermediate-grade colorectal adenomas: a retrospective cohort analysis, and psychological and economic evaluations
2017     HAYES, Inc. Magnetic resonance imaging–guided in-bore biopsy for prostate cancer
2017     NIHR Health Technology Assessment programme Multiplex tests to identify gastrointestinal bacteria, viruses and parasites in people with suspected infectious gastroenteritis: a systematic review and economic analysis